Analyst Research Report Snapshot

Title:

Celgene Corporation

Price:

$175.00

Provider:

MarketLine (a Datamonitor Company)

Date:

08 Apr 2014

Pages:

49

Type:

AcrobatPDF

Companies referenced:

CELG.OQ

Available for Immediate Download
Summary:

Celgene Corporation - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company. Features: - Detailed information on Celgene Corporation required for business and competitor intelligence needs - A study of the major internal and external factors affecting Celgene Corporation in the form of a SWOT analysis - An in-depth view of the business model of Celgene Corporation including a breakdown and examination of key business segments - Intelligence on Celgene Corporation’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors - News about Celgene Corporation, such as business expansion, restructuring, and contract wins - Large number of easy-to-grasp charts and graphs that present important data and key trends Highlights: Celgene (or 'the company'), an integrated biopharmaceutical company, is engaged in the research, development and marketing of novel therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. The company operates in the US, Europe and Asia Pacific. It is headquartered in Summit, New Jersey, and employed 4,700 people as of December 31, 2012. The company recorded revenues of $5,506.7 million during the financial year ended December 2012 (FY2012), an increase of 13.7% over FY2011. The operating profit of the company was $1,746.4 million in FY2012, an increase of 21% over FY2011. The net profit was $1,456.2 million in FY2012, an increase of 10.5% over FY2011. Reasons to Purchase: - Gain understanding of Celgene Corporation and the factors that influence its strategies - Track strategic initiatives of the company and latest corporate news and actions - Assess Celgene Corporation as a prospective partner, vendor or supplier - Support sales activities by understanding your customers' businesses better - Stay up to date on Celgene Corporation’s business structure, strategy and prospects

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.